What are iRadimed's profit margins?

iRadimed (IRMD) runs a 76.8% gross margin and a 32.4% operating margin, with a 27.4% net margin.

Where do iRadimed's ratios come from?

Every ratio is computed from iRadimed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

iRadimed IRMD Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	76.8%-0.1pp	76.7%-0.2pp	77.1%-0.1pp	77%-0.2pp	76.9%+0.3pp
Operating margin	32.4%+2.3pp	31.2%+1.2pp	30.9%+1.0pp	30.7%-0.2pp	30.1%-0.6pp
Net margin	27.4%+1.0pp	26.8%+0.6pp	26.3%+0.2pp	26.6%-0.2pp	26.3%-0.2pp
Returns
Return on equity	25%+1.2pp	24.8%+0.5pp	23.3%-0.3pp	23.7%-1.3pp	23.8%-1.7pp
Efficiency
Asset turnover	0.8×0.0×	0.8×0.0×	0.8×0.0×	0.8×0.0×	0.8×0.0×
Liquidity
Current ratio	7.1×-1.7×	8×-0.9×	6.6×-2.6×	8.8×-1.1×	8.9×-0.6×
Per Share
Book value per share	$7.65+9.0%	$7.36+8.4%	$7.65+17.1%	$7.35+17.6%	$7.02+17.6%
Valuation
Market capitalization	$1.21B+63.4%	$1.24B+77.5%	$905.16M+42.1%	$769.01M+38.2%	$667.29M+19.8%
Price / earnings	51.3×+13.8×	55.1×+18.8×	42.7×+8.5×	37.2×+7.4×	33.7×+2.6×
Price / sales	14×+4.2×	14.8×+5.2×	11.2×+2.3×	9.9×+1.9×	8.9×+0.6×
Price / book	12.3×+4.1×	13.1×+5.1×	9.2×+1.6×	8.2×+1.2×	7.4×+0.1×
Dividend yield	1.3%+0.2pp	1.2%-0.7pp	0.9%—	1.1%—	1.2%—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about iRadimed.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are iRadimed's profit margins?: iRadimed (IRMD) runs a 76.8% gross margin and a 32.4% operating margin, with a 27.4% net margin.
Where do iRadimed's ratios come from?: Every ratio is computed from iRadimed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.